List of Contents

Albumin Market Size, Share, and Trends 2024 to 2034

The global albumin market size was USD 6.38 billion in 2023, calculated at USD 6.74 billion in 2024 and is expected to be worth around USD 11.64 billion by 2034. The market is slated to expand at 5.62% CAGR from 2024 to 2034.

  • Last Updated : October 2024
  • Report Code : 5083
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Albumin Market 

5.1. COVID-19 Landscape: Albumin Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Albumin Market, By Product

8.1. Albumin Market Revenue and Volume, by Product, 2024-2034

8.1.1 Human Albumin

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. Bovine Albumin

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

8.1.3. Recombinant Albumin

8.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Albumin Market, By Application

9.1. Albumin Market Revenue and Volume, by Application, 2024-2034

9.1.1. Drug Formulation

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Therapeutics

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

9.1.3. Others

9.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Albumin Market, By End-user

10.1. Albumin Market Revenue and Volume, by End-user, 2024-2034

10.1.1. Hospitals and Clinics

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. Pharmaceutical Companies

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

10.1.3. Research Institutions

10.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Albumin Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.1.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.1.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.1.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.1.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.1.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.1.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.2.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.2.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.2.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.2.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.6.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.2.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.7.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.3.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.3.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.3.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.3.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.6.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.3.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.7.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.4.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.4.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.4.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.6.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.4.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.7.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.5.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.5.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.5.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.5.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

Chapter 12. Company Profiles

12.1. Octapharma AG

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Albumedix Ltd.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Biotest AG

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Grifols SA

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. HiMedia Laboratories

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Medxbio Pte Ltd.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. CSL Limited

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Merck KGaA

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Takeda Pharmaceutical Company Limited

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Ventria Bioscience Inc.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us